These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31738149)
1. Rosmarinic Acid as a Potent Influenza Neuraminidase Inhibitor: Mahalapbutr P; Sangkhawasi M; Kammarabutr J; Chamni S; Rungrotmongkol T Curr Top Med Chem; 2020; 20(23):2046-2055. PubMed ID: 31738149 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors. Chen BL; Wang YJ; Guo H; Zeng GY Eur J Med Chem; 2016 Feb; 109():199-205. PubMed ID: 26774928 [TBL] [Abstract][Full Text] [Related]
3. Caffeic acid derivatives: a new type of influenza neuraminidase inhibitors. Xie Y; Huang B; Yu K; Shi F; Liu T; Xu W Bioorg Med Chem Lett; 2013 Jun; 23(12):3556-60. PubMed ID: 23664211 [TBL] [Abstract][Full Text] [Related]
4. Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors. Xie Y; Huang B; Yu K; Xu W Bioorg Med Chem; 2013 Dec; 21(24):7715-23. PubMed ID: 24262883 [TBL] [Abstract][Full Text] [Related]
5. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1. Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic, genotoxic and antimicrobial activity of caffeic and rosmarinic acids and their lithium, sodium and potassium salts as potential anticancer compounds. Matejczyk M; Świsłocka R; Golonko A; Lewandowski W; Hawrylik E Adv Med Sci; 2018 Mar; 63(1):14-21. PubMed ID: 28818744 [TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs. Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors. Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229 [TBL] [Abstract][Full Text] [Related]
9. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Hussain Basha S; Prasad RN BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192 [TBL] [Abstract][Full Text] [Related]
10. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease. Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117 [TBL] [Abstract][Full Text] [Related]
11. Contribution of cinnamic acid analogues in rosmarinic acid to inhibition of snake venom induced hemorrhage. Aung HT; Furukawa T; Nikai T; Niwa M; Takaya Y Bioorg Med Chem; 2011 Apr; 19(7):2392-6. PubMed ID: 21388814 [TBL] [Abstract][Full Text] [Related]
12. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study. Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548 [TBL] [Abstract][Full Text] [Related]
13. Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study. Yang Z; Yang G; Zhou L J Comput Aided Mol Des; 2013 Nov; 27(11):935-50. PubMed ID: 24218291 [TBL] [Abstract][Full Text] [Related]
14. Discovery of novel acylhydrazone neuraminidase inhibitors. Zhao ZX; Cheng LP; Li M; Pang W; Wu FH Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584 [TBL] [Abstract][Full Text] [Related]
15. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1. Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988 [TBL] [Abstract][Full Text] [Related]
16. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus. Márquez-Domínguez L; Reyes-Leyva J; Herrera-Camacho I; Santos-López G; Scior T Molecules; 2020 Sep; 25(18):. PubMed ID: 32947893 [TBL] [Abstract][Full Text] [Related]
17. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus. Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858 [TBL] [Abstract][Full Text] [Related]
18. Recent progress and challenges in the discovery of new neuraminidase inhibitors. Chamni S; De-Eknamkul W Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206 [TBL] [Abstract][Full Text] [Related]
19. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV). Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866 [TBL] [Abstract][Full Text] [Related]
20. [Design, synthesis and activity of a new type of influenza virus N1 neuraminidase inhibitors]. Yang F; Jin L; Huang NY; Chen F; Luo HJ; Chen JF Yao Xue Xue Bao; 2011 Nov; 46(11):1344-8. PubMed ID: 22260026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]